Perceptive Capital Solutions, a blank check company backed by Perceptive Advisors targeting healthcare, raised $75 million by offering 7.5 million shares at $10. The offering did not contain warrants or rights.
The company is led by Chairman Joseph Edelman, the founder, CEO, and Portfolio Manager of life sciences-focused investment firm Perceptive Advisors, and CEO and Director Adam Stone, the CIO of Perceptive Advisors. It plans to target the healthcare or healthcare-related industries, particularly North American or European companies in the life sciences and medical technology sectors.
Perceptive Advisors has backed several previous SPACs, most recently ARYA Sciences Acquisition IV (ARYD; +15% from $10 offer price), which has a pending merger agreement with cryoablation firm Adagio Medical, and ARYA Sciences Acquisition V, which liquidated in 2023. Other past SPACs include ARYA Sciences Acquisition III, which merged with proteomics platform Nautilus Biotechnology (Nasdaq: NAUT; -73%) in 2021; ARYA Sciences Acquisition II, which merged with neuroscience biotech Cerevel Therapeutics (Nasdaq: CERE; +303%) in 2020; and ARYA Sciences Acquisition, which merged with cancer biotech Immatics (Nasdaq: IMTX; +33%) in 2020.
Perceptive Capital Solutions plans to list on the Nasdaq under the symbol PCSC. Jefferies acted as sole bookrunner on the deal.
